Picture of Fresenius SE & Co. KGaA logo

FRE — Fresenius SE & Co. KGaA News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Germany's Fresenius raises 2026 core EPS growth guidance

Germany's Fresenius raises 2026 core EPS growth guidance


Overview

  • Germany healthcare group's Q2 organic revenue rose 6% yr/yr to €5.86 bln

  • Core EPS for Q2 rose 14% in constant currency to €0.83

  • Company raised 2026 core EPS growth guidance to 10%-15% citing strong operational performance


Outlook

  • Fresenius raises 2026 core EPS guidance to 10%-15% constant-currency growth

  • Company expects 2026 group organic revenue growth of 4%-7%

  • Company notes ongoing macroeconomic and geopolitical volatility increasing operational uncertainty


Result Drivers

  • CORE BUSINESS PERFORMANCE - Co said strong operational performance at Fresenius Kabi and Fresenius Helios supported earnings development

  • NET INTEREST INCOME - Improved net interest income contributed to earnings growth


Company press release: ID:nEQ8Kgb1Ra


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

EUR 5.86 bln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 17 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the healthcare facilities & services peer group is "buy"

  • Wall Street's median 12-month price target for Fresenius SE & Co KGaA is €54.00, about 21.7% above its August 4 closing price of €44.36

  • The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 11 three months ago


Reuters Recommended Reads

  • Aug 4 - Dialysis firm FMC's shares slide despite earnings beat as US volumes disappoint again

  • Aug 4 - Bayer CEO says company now in a better position to make strategic choices

  • Aug 4 - BioNTech lowers 2026 sales outlook as COVID vaccine demand softens


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Fresenius SE & Co. KGaA

See all news